Moderna, Merck Cancer Vax Gives Hope

Merck and Moderna's mRNA cancer vaccine reduced melanoma recurrence in a late-stage trial. The vaccine, which trains the immune system to identify and attack cancer cells, represents a step forward in cancer vaccine development. The trial results were announced following earlier research into mRNA vaccine technology.

Next story